Therefore, the four human breast cancer cell lines (MBA-MD-231, MCF-7, BT-474 and T-47D) were chosen to identify the mechanism of action by which SPA inhibits breast cancer cell proliferation and motility and the potential involvement of Brk and FAK signaling. Here, PTK2 is linked to breast carcinoma.